外来がん化学療法における薬剤師の関与のあり方  [in Japanese] Participation of Pharmacists in Outpatient Chemotherapy  [in Japanese]

Search this Article

Author(s)

    • 日野 美波理 HINO Bibari
    • 岡山大学医学部・歯学部附属病院薬剤部 Department of Hospital Pharmacy, Okayama University Medical and Dental School
    • 石井 雅人 ISHII Masato
    • 岡山大学医学部・歯学部附属病院薬剤部 Department of Hospital Pharmacy, Okayama University Medical and Dental School
    • 藤原 聡子 FUJIWARA Satoko
    • 岡山大学医学部・歯学部附属病院薬剤部 Department of Hospital Pharmacy, Okayama University Medical and Dental School
    • 松香 直行 MATSUKA Naoyuki
    • 岡山大学医学部・歯学部附属病院薬剤部 Department of Hospital Pharmacy, Okayama University Medical and Dental School
    • 定金 典明 SADAKANE Noriaki
    • 岡山大学医学部・歯学部附属病院薬剤部 Department of Hospital Pharmacy, Okayama University Medical and Dental School
    • 森山 雅弘 MORIYAMA Masahiro
    • 岡山大学医学部・歯学部附属病院薬剤部 Department of Hospital Pharmacy, Okayama University Medical and Dental School
    • 柴田 和彦 SHIBATA Kazuhiko
    • 岡山大学医学部・歯学部附属病院薬剤部 Department of Hospital Pharmacy, Okayama University Medical and Dental School
    • 五味田 裕 GOMITA Yutaka
    • 岡山大学医学部・歯学部附属病院薬剤部 Department of Hospital Pharmacy, Okayama University Medical and Dental School

Abstract

Owing to the approval of reimbursement of fees for antineoplastic chemotherapy on an outpatient basis by the national health insurance scheme in April 2002, an antineoplastic chemotherapy room was set up in the ambulatory area of our hospital in August 2000. In order to ensure the effective use of the safety cabinet and other existing equipment and the safe administration of antineoplastic agents to patients, the authors assigned a mixing pharmacist and a coordinating pharmacist who was to be in charge of antineoplastic chemotherapy for outpatients.<BR>First, the mixing pharmacist prepared IV mixtures of the antineoplastic agents and auxiliary medicines in a sterile area and then the coordinating pharmacist audited the mixtures and carried them to the antineoplastic chemotherapy room. Other functions of the coordinating pharmacist included providing pharmaceutical care to patients and cooperating with doctors, nurses and other pharmacists involved in the chemotherapy. They also searched for information on individual medical charts or in patient statements and pointed out doubtful records or potential problems that might affect chemotherapy. Coordinating pharmacists notified 50 potential problems between August 2002 and April 2003.<BR>To evaluate our pharmaceutical practices in outpatient antineoplastic chemotherapy, we conducted a questionnaire survey of the patients. Their responses indicated that our pharmaceutical care program was working well and that they hoped we would continue it. However, the usefulness of our program was not entirely clear to all patients and we recognized the need to better inform patients concerning this.

Journal

  • Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)

    Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 30(7), 457-467, 2004-07-10

    Japanese Society of Pharmaceutical Health Care and Sciences

References:  6

Cited by:  7

Codes

  • NII Article ID (NAID)
    110001166826
  • NII NACSIS-CAT ID (NCID)
    AA11527197
  • Text Lang
    JPN
  • Article Type
    Journal Article
  • ISSN
    1346342X
  • Data Source
    CJP  CJPref  NII-ELS  J-STAGE  NDL-Digital 
Page Top